Maite Rodriguez is a Clinical Rater at NewGen Health Group with specialized expertise in behavioral health assessments, psychiatric evaluations, and patient-reported outcomes for clinical research studies. She holds a Bachelor’s Degree in Psychology from Florida International University and a Master’s Degree in Behavior Analysis and Education Training from the Universidad Complutense de Madrid. 

With a strong background in psychology, behavioral analysis, psychosocial rehabilitation, and patient care, Ms. Rodriguez is experienced in conducting clinical interviews, administering rating scales, and evaluating study participants for eligibility and outcome assessments. Her work focuses on ensuring the accuracy, consistency, and integrity of clinical endpoint data while maintaining a patient-centered approach throughout the research process. 

Prior to joining NewGen Health Group, Ms. Rodriguez worked extensively with individuals experiencing psychiatric, developmental, and behavioral health conditions, providing counseling support, psychosocial rehabilitation services, and case management. Her experience working with diverse patient populations, combined with her bilingual English and Spanish fluency, allows her to effectively engage participants and support successful recruitment, retention, and study compliance. 

As a dedicated Clinical Rater, Ms. Rodriguez plays a critical role in generating reliable clinical outcomes data and supporting high-quality execution of CNS, psychiatry, neurology, and behavioral health clinical trials. Her expertise in standardized assessments and patient evaluations makes her a valuable asset for pharmaceutical sponsors and CROs seeking consistent, high-quality endpoint measurements. 

• Experienced Clinical Rater specializing in psychiatric and behavioral health assessments.
• Master’s Degree in Behavior Analysis and Education Training.
• Bachelor’s Degree in Psychology.
• Skilled in administering standardized rating scales and clinical interviews.
• Experienced in patient eligibility evaluations and outcome assessments.
• Bilingual English and Spanish patient engagement capabilities.
• Strong focus on data quality, consistency, and protocol compliance.
• Supports CNS, Psychiatry, Neurology, Alzheimer’s Disease, Depression, Bipolar Disorder, Schizophrenia, Anxiety, and Behavioral Health clinical trials.
• Enhances participant retention through compassionate, patient-centered interactions.